Table 3.
Wu-ling-san group | Placebo group |
P value (% of change) |
|||||
Pretreatment | Post-treatment | % of change | Pretreatment | Post-reatment | % of change | ||
Serum BUN (mg/dl) | 14.7 ± 2.7 | 13.8 ± 3.9 | −6.9% | 15.1 ± 4.6 | 16.9 ± 5.3 | 13.8% | 0.006* |
Serum Cr (mg/dl) | 1.1 ± 0.1 | 1.1 ± 0.1 | −0.4% | 1.2 ± 0.1 | 1.2 ± 0.2 | 2.8% | 0.44 |
Serum GOT (IU/L) | 24.6 ± 12.1 | 23.7 ± 9.6 | −0.04% | 23.6 ± 6.6 | 22.2 ± 7.0 | −4.3% | 0.60 |
Serum GPT (IU/L) | 36.0 ± 32.1 | 36.7 ± 27.9 | 7.7% | 32.8 ± 18.4 | 31.1 ± 20.1 | −4.9% | 0.25 |
Data presented as mean ±SD
Percentage of change between groups P < 0.05 (independent t-test)